T Balderi, F Carli - Minerva anestesiologica, 2010 - europepmc.org
Postoperative urinary retention (POUR) occurs after lower joint arthroplasty with an incidence between 0% and 75%. This vast range reflects the differences in diagnosis and …
LS Bjerregaard, S Bogø, S Raaschou… - Acta …, 2015 - Taylor & Francis
Background and purpose—Postoperative urinary retention (POUR) is a clinical challenge, but there is no scientific evidence for treatment principles. We describe the incidence of and …
CM Lawrie, AC Ong, VH Hernandez, S Rosas… - The Journal of …, 2017 - Elsevier
Background The objective of this study is to determine the risk factors for postoperative urinary retention (POUR) following total hip arthroplasty (THA) under spinal anesthesia …
A Casati, G Fanelli, G Danelli, M Berti… - Anesthesia & …, 2007 - journals.lww.com
BACKGROUND: In this prospective, randomized, double-blind study we tested the hypothesis that 50 mg of 1% preservative-free 2-chloroprocaine would provide a faster …
R Scholten, K Kremers, SAW van de Groes… - The Journal of …, 2018 - Elsevier
Background Postoperative urinary retention (POUR) appears to be a common complication in lower limb joint arthroplasty; however, reports on its incidence vary. There is no general …
SG Naidu, H Narayanan, G Saini, N Segaran… - Journal of clinical …, 2021 - mdpi.com
Lower urinary tract symptoms (LUTS) due to benign prostatic hypertrophy (BPH) are a very common problem in men ranging from mild urinary symptoms to recurrent urinary tract …
YH Cha, YK Lee, SH Won, JW Park… - Journal of …, 2020 - journals.sagepub.com
Purpose: Postoperative urinary retention (POUR) is a common complication after total joint arthroplasties (TJAs). The POUR is managed with urinary catheterization, which is …
Background Postoperative urinary retention (POUR) is a source of avoidable patient harm. The aim of this review is to identify and quantify the role of patient-related risk factors in the …
D Mamilla, KA Araque, A Brofferio, MK Gonzales… - Cancers, 2019 - mdpi.com
Pheochromocytomas and paragangliomas (PPGLs) are rare catecholamine-secreting neuroendocrine tumors of the adrenal medulla and sympathetic/parasympathetic ganglion …